Large Molecule Research & Perspectives

  1. How Automation, Biometrics, And VR Are Redefining Quality Standards 7/6/2026

    Modernize quality control by integrating automated workflows, digital records, and advanced training. Eliminating paper protects data integrity and accelerates regulatory timelines.

  2. Supply Chain Resilience In Multi-Continent Biopharma Manufacturing 7/6/2026

    Multi-continent manufacturing networks minimize supply chain risk. Relying on site alignment, robust tech transfer, and unified quality standards ensures a flexible and resilient supply chain.

  3. Redefining Value In Biologics Outsourcing Partnerships 6/25/2026

    Biologics outsourcing is shifting to strategic partnerships focused on modality expertise, regulatory excellence, and integrated end-to-end capabilities.

  4. Navigating The BIOSECURE Act Landscape 6/22/2026

    Supply chain visibility and proactive risk strategies are vital to navigate new federal biotech restrictions and protect drug development pipelines.

  5. ADCs As Biological Missiles For Targeted Therapies 6/15/2026

    Antibody-drug conjugates are reshaping cancer treatment. Learn how monoclonal antibody targeting, linker design, and next-gen payloads are defining the future of precision oncology.

  6. Tech Transfer In CDMOs: Avoiding The Scale-Up Trap 6/15/2026

    Tech transfer at a CDMO is a stress test, not a handover. Learn why lab-ready processes fail at scale and what chemical process development must address before manufacturing starts.

  7. Batch Manufacturing Vs Continuous Manufacturing With Process Analytical Technology 6/15/2026

    Batch or continuous manufacturing? The answer depends heavily on how you use process analytical technology. Understand the tradeoffs before your next program decision.

  8. Self-Amplifying RNA: The Next Chapter In mRNA Therapeutics 6/5/2026

    Self-amplifying RNA builds on mRNA technology by enabling intracellular replication, delivering stronger and longer-lasting responses at lower doses while improving scalability, cost-efficiency, and global accessibility.

  9. How Integrated Molecule Innovation Is Transforming Vet Therapeutics 5/27/2026

    Cell line development underpins modern animal health innovation, enabling production of targeted biologics and supporting integrated approaches that improve therapeutic precision, scalability, and treatment outcomes.

  10. Balancing Timelines In Outsourced R&D With GXP Compliance 5/27/2026

    Outsourced R&D balances speed and quality by integrating strong governance, clear planning, and GXP compliance, enabling efficient execution while reducing risk, rework, and development delays.